z-logo
open-access-imgOpen Access
Ritonavir‐boosted protease inhibitor monotherapy is 6% less effective than combination antiretroviral therapy in a meta‐analysis
Author(s) -
Bierman WFW,
Humphreys EH,
Agtmael MA,
Boucher CA,
Rutherford GW
Publication year - 2010
Publication title -
journal of the international aids society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.724
H-Index - 62
ISSN - 1758-2652
DOI - 10.1186/1758-2652-13-s4-o18
Subject(s) - medicine , ritonavir , protease inhibitor (pharmacology) , antiretroviral therapy , combination therapy , pharmacotherapy , meta analysis , virology , pharmacology , human immunodeficiency virus (hiv) , viral load
7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here